Be part of the knowledge.™

Endocrinology

554

LikeLikedUnlike

46-60 of 70

MinuteCE®
Bridging the Gap: ns-MRAs in Cardiovascular-Kidney-Metabolic Syndrome Care
- Pardeep Jhund, MD, PhD
- Hiddo L. Heerspink, PhD
- John McMurray, MD
- Akshay S. Desai, MD
- Csaba P. Kovesdy, MD
- Finnian R. McCausland, MD
- Orly Vardeny, MD
- Muthiah Vaduganathan, MD, MPH
1.25 credits 10 episodes
Emerging Evidence in HF Care
MinuteCE®
Emerging Evidence in HF Care
- Pardeep Jhund, MD, PhD
- John McMurray, MD
1.25 program credits
Nonsteroidal MRAs: The CKD/T1D Potential
MinuteCE®
Nonsteroidal MRAs: The CKD/T1D Potential
- John McMurray, MD
- Hiddo L. Heerspink, PhD
1.25 program credits
Nonsteroidal MRAs: The CKD/T2D Advantage
MinuteCE®
Nonsteroidal MRAs: The CKD/T2D Advantage
- John McMurray, MD
- Pardeep Jhund, MD, PhD
1.25 program credits
MOA Deep Dive: The MRA Spectrum
MinuteCE®
MOA Deep Dive: The MRA Spectrum
- John McMurray, MD
- Hiddo L. Heerspink, PhD
1.25 program credits
Overcoming Clinical Inertia in Hyperkalemia Management
CME/CE
Overcoming Clinical Inertia in Hyperkalemia Management
- Peter Rossing, MD, DMSc
- Michael Böhm, MD, FESC
- Luca De Nicola, MD, PhD
0.25 credits
advertisement
MinuteCE®
The Future of ADH1 - Looking at Emergent Treatments
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 credits 4 episodes
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®
CASR and ADH1: Integrating Biology and Genetic Screening
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®
Therapeutic Options for ADH1 and Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®
Emerging Therapeutics in ADH1: Progress in Precision Medicine
- Michael A. Levine, MD, FAAP, MACE, FACP
- B. Michelle Schweiger, DO, MPH
1.00 program credits
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CE
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
- Scott Kahan, MD, MPH
- Ken Fujioka, MD
- Carol Wysham, MD
0.50 credits
advertisement
Shared Decision-Making in Cushing’s Disease
MinuteCE®
Shared Decision-Making in Cushing’s Disease
- Maria Fleseriu, MD, FACE
- Richard Auchus, MD
1.00 program credits
MinuteCE®
Optimizing Outcomes of Cushing’s Disease Through Strategic Screening, Early Diagnosis, and Timely Treatment
- Maria Fleseriu, MD, FACE
- Richard Auchus, MD
- Martin Reincke, MD
1.00 credits 8 episodes
Diagnostic Delay and the Critical Role of Personalized Screening Approaches in Cushing’s Syndrome
CME/CE
Diagnostic Delay and the Critical Role of Personalized Screening Approaches in Cushing’s Syndrome
- Maria Fleseriu, MD, FACE
- Martin Reincke, MD
0.25 credits

Program Chapters

Segment Chapters

Playlist:

Recommended